Global Pressure Ulcers Treatment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Treatment Type;
Wound Care Dressings - [Antimicrobial Dressings, Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings & Other Dressings], Wound Care Devices - [Negative Pressure Wound Therapy (NPWT), Ultrasound Therapy & Others (HBOT and electromagnetic therapy)], Active Therapies - [Skin Grafts & Substitutes, Growth Factors, Others (hemostatic agents and sealants (collagen & fibrin sealants))], and Others - [Traditional Wound Care Products, Pressure Relief Devices, and Others]By Type of Wound;
Stage 1, Stage 2, Stage 3, and Stage 4By End Users;
Hospital Inpatient Settings, Hospital Outpatient Settings, Community Health Centers, and Home Health CareBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Pressure Ulcers Treatment Market Overview
Global Pressure Ulcers Treatment Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 4.8 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 4.8 % |
Market Size (2024) | USD 21,339.12 Million |
Market Size (2031) | USD 29,667.82 Million |
Market Concentration | High |
Report Pages | 335 |
Major Players
- Smith & Nephew plc
- Integra LifeSciences Corporation
- Hill-Rom Holdings, Inc.
- Mölnlycke Health Care AB
- Essity Aktiebolag
- Cardinal Health
- 3M Healthcare
- B. Braun Melsungen AG
- Acelity L.P., Inc.
- Coloplast Group
- ConvaTec
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Pressure Ulcers Treatment Market
Fragmented - Highly competitive market without dominant players
Pressure Ulcers Treatment Market (USD Million)
Pressure Ulcers Treatment Market was valued at USD 21,339.12 million in the year 2024. The size of this market is expected to increase to USD 29,667.82 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.8%.
The Pressure Ulcers Treatment Market is experiencing substantial momentum due to the increasing prevalence of chronic wounds and rising awareness of advanced wound care solutions. A notable rise in hospital-acquired pressure injuries and long-term immobility cases is fueling demand. With growing healthcare expenditure, the adoption of innovative dressings, devices, and biologics has expanded rapidly. The market has seen an estimated growth rate of over 6% in recent years, driven by both public and private healthcare investments.
Drivers of Market Growth
A major contributor to this market’s expansion is the growing geriatric population, which is highly susceptible to pressure ulcers due to limited mobility. Additionally, the increasing incidence of diabetes and obesity has amplified the risk of skin breakdown. Hospitals and home care settings are shifting toward moist wound healing techniques, contributing to a market adoption rise of approximately 8% across advanced therapies. This trend reflects the market’s shift from traditional to more effective solutions.
Technological Advancements
Rapid innovation in wound care devices and biologics has revolutionized pressure ulcer treatment. Technologies like negative pressure wound therapy and hydrocolloid dressings have gained significant traction, accounting for over 15% increase in demand within specialty care settings. These advancements not only promote faster healing but also reduce infection risks and hospital stays, driving long-term cost efficiency in treatment regimens.
Future Outlook
Looking ahead, the market is expected to benefit from ongoing investments in research and clinical trials aimed at improving wound care efficacy. The growing role of telehealth and remote monitoring technologies is anticipated to further elevate treatment adherence and outcomes. With an increasing emphasis on patient-centric care, the market could witness an estimated uptake surge of 10% in emerging therapeutic platforms over the coming years.
Pressure Ulcers Treatment Market Recent Developments
-
In March 2019, Smith & Nephew plc, a U.K.-based medical technology company, agreed to acquire Osiris Therapeutics, a fast-growing company delivering regenerative medicine products, including skin, bone graft, and articular cartilage substitutes, for US$ 19.00 per share in cash, representing a total equity value of around US$ 660 Mn.
-
In January 2019, Mölnlycke Health Care AB announced the acquisition of M&J Airlaid Products A/S (“M&J”). M&J is a Denmark-based private company and manufacturer of specialized and high-quality absorbent Airlaid nonwoven materials. M&J’s Airlaid technology is critical, along with foams and soft silicone, in Mölnlycke’s wound care products.
Pressure Ulcers Treatment Market Segment Analysis
In this report, the Pressure Ulcers Treatment Market has been segmented by Treatment Type, Type of Wound, End Users and Geography.
Pressure Ulcers Treatment Market , Segmentation by Treatment Type
The Pressure Ulcers Treatment Market has been segmented by Treatment Type into Wound Care Dressings, Wound Care Devices, Active Therapies and Others.
Wound Care Dressings
This segment holds the largest share at approximately 45%, driven by the widespread use of hydrocolloid, foam, and alginate dressings for managing pressure ulcers at various stages. These dressings help maintain a moist wound environment, reduce infection risks, and support faster healing.
Wound Care Devices
Wound care devices account for nearly 30% of the market, including technologies such as negative pressure wound therapy (NPWT) and electrical stimulation devices. These tools enhance tissue regeneration and are frequently used in hospital and surgical care settings for severe ulcers.
Active Therapies
Active therapies represent about 18% of the market, involving advanced options like growth factors, skin substitutes, and biologic agents. These therapies are especially beneficial for chronic, non-healing wounds and are gaining traction in specialty wound care centers.
Others
The others category makes up the remaining 7% and includes supportive care such as pain management, nutritional support, and topical antimicrobials. These are often used in conjunction with primary treatments to enhance patient outcomes and reduce complication rates.
Pressure Ulcers Treatment Market , Segmentation by Type of Wound
The Pressure Ulcers Treatment Market has been segmented by Type of Wound into Stage 1, Stage 2, Stage 3 and Stage 4.
Stage 1
Stage 1 pressure ulcers account for about 20% of total cases and are characterized by non-blanchable redness of intact skin. Treatment at this stage focuses on pressure redistribution, skin protection, and the use of moisturizing agents to prevent progression to more severe stages.
Stage 2
Stage 2 ulcers represent approximately 30% of the market and involve partial-thickness skin loss with exposure of the dermis. Management typically includes foam dressings, hydrocolloids, and protective barriers to support wound closure and minimize infection risk.
Stage 3
Stage 3 wounds account for around 28% of cases and are marked by full-thickness skin loss, often exposing fat tissue. Treatment involves the use of advanced wound care devices like NPWT and debridement therapies to promote granulation and tissue regeneration.
Stage 4
Stage 4 ulcers make up roughly 22% of the market and are the most severe, often exposing muscle, bone, or supporting structures. These wounds require intensive intervention using biologic dressings, skin grafts, and infection control measures to support healing and reduce complications.
Pressure Ulcers Treatment Market , Segmentation by End Users
The Pressure Ulcers Treatment Market has been segmented by End Users into Hospital Inpatient Settings, Hospital Outpatient Settings, Community Health Centers and Home Health Care.
Hospital Inpatient Settings
This segment holds the largest share at approximately 40%, owing to the high prevalence of severe pressure ulcers among immobilized and post-surgical patients. Hospitals often utilize advanced wound care dressings, NPWT systems, and biologic therapies to manage complex wounds in critical care units.
Hospital Outpatient Settings
Hospital outpatient settings account for nearly 25% of the market, catering to follow-up wound care visits and moderate-stage ulcer management. These settings emphasize cost-effective therapies, quick intervention, and regular wound monitoring to reduce the risk of readmission.
Community Health Centers
This segment contributes around 18%, playing a vital role in providing localized wound care and preventive services. Community health centers use standard dressings, pressure redistribution cushions, and educational outreach to support high-risk populations in underserved areas.
Home Health Care
Home health care represents roughly 17% of the market and is growing steadily due to the rising preference for personalized, in-home treatment. Services in this setting focus on portable wound care devices, home dressing kits, and nurse-assisted monitoring for elderly or immobile patients.
Pressure Ulcers Treatment Market, Segmentation by Geography
In this report, the Pressure Ulcers Treatment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Pressure Ulcers Treatment Market Share (%), by Geographical Region
North America
North America leads the global market with a share of around 38%, driven by a high prevalence of chronic wounds, advanced healthcare infrastructure, and widespread use of technologically advanced wound care products. The U.S. remains the dominant contributor due to extensive hospital networks and increased focus on pressure ulcer prevention programs.
Europe
Europe holds nearly 28% of the market share, supported by a growing geriatric population, favorable reimbursement policies, and rising public awareness regarding pressure ulcer management. Countries such as Germany, the UK, and France are leading adopters of advanced dressings and active therapies.
Asia Pacific
Asia Pacific accounts for approximately 22% of the global market and is poised for rapid growth due to rising healthcare expenditure, an increasing number of aging individuals, and expanding hospital infrastructure. India, China, and Japan are major contributors with growing demand for cost-effective wound care solutions.
Middle East and Africa
This region contributes about 6% to the market, with demand primarily concentrated in GCC countries and South Africa. Rising investment in hospital facilities and growing initiatives for wound care education are supporting the adoption of both low-tech and high-tech treatment options.
Latin America
Latin America holds nearly 6% of the market, with Brazil and Mexico as key markets. Improvements in public healthcare systems, increasing pressure ulcer awareness campaigns, and broader access to advanced wound dressings are contributing to market expansion in this region.
Pressure Ulcers Treatment Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Pressure Ulcers Treatment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis,
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers
- Rising Prevalence Of Chronic Bedridden Conditions
- Increasing Geriatric And Immobile Patient Population
- Advancements In Wound Healing Technologies
-
Awareness Programs On Pressure Ulcer Prevention - Awareness programs on pressure ulcer prevention are significantly accelerating demand for treatment solutions across healthcare systems. As medical staff and caregivers grow more informed about the risks of pressure injuries, there is an increased focus on proactive care. This rising awareness is encouraging the routine use of effective wound care products in both institutional and home-based settings.
Public health organizations, hospitals, and wound care associations are launching targeted campaigns to promote early-stage intervention, especially among high-risk populations. These programs offer practical training on repositioning, skin monitoring, and product selection. As these efforts expand, facilities are integrating pressure ulcer prevention into daily protocols, leading to stronger market adoption.
Performance-based reimbursements and care quality incentives are reinforcing the implementation of best practices. These financial motivators ensure providers prioritize early ulcer management to avoid complications and extended hospital stays. As a result, investment in reliable treatment solutions has increased across various levels of care. Improved caregiver education and patient engagement are further propelling the shift toward prevention-first strategies. This change in care mindset is leading to stronger clinical outcomes and driving long-term growth for pressure ulcer treatment products globally.
Restraints
- High Cost Of Advanced Treatment Products
- Limited Reimbursement In Certain Developing Regions
- Lack Of Trained Wound Care Specialists
-
Product Access Gaps In Rural Settings - Limited access to advanced wound care products in rural areas continues to hinder the pressure ulcers treatment market. Patients in remote or underserved locations often rely on outdated or ineffective remedies, which increases healing times and raises the likelihood of severe complications. Supply chain constraints and inadequate distribution are core challenges preventing rural clinics from maintaining inventories of modern pressure ulcer treatments. Even when care facilities are operational, the absence of advanced dressings or devices limits the quality of care provided, particularly for chronic cases.
Insufficient training and lack of wound care specialists in these regions also contribute to misdiagnosis or under-treatment. Without the expertise to properly use advanced products, caregivers are forced to apply basic solutions that may not support full healing. Reimbursement limitations and affordability issues worsen this disparity. Strategic outreach through mobile clinics and telehealth platforms is essential to close this gap. Expanding rural access is critical not only to address healthcare inequality but also to unlock untapped market potential for pressure ulcer treatment innovations.
Opportunities
- Technological Innovations In Dressing Materials
- Growing Demand For Home-Based Ulcer Care
- Public-Private Partnerships For Wound Management
-
Integration Of AI In Ulcer Monitoring - Integrating artificial intelligence in ulcer monitoring offers a breakthrough opportunity for the market. AI-powered systems can detect early signs of skin damage, assess wound progression, and deliver data-driven insights to support faster and more effective clinical responses. Smart imaging and predictive tools are enabling real-time wound tracking. Mobile applications and wearable sensors are gaining traction for continuous monitoring, especially in long-term care environments. These technologies empower general healthcare providers to manage complex ulcers with greater precision and consistency.
Data collected from AI platforms supports large-scale analytics and can be linked to electronic health records. This allows seamless collaboration across multidisciplinary teams and ensures optimized treatment pathways, even in decentralized care models. As digital health adoption increases globally, AI-enabled pressure ulcer solutions are expected to play a pivotal role in reshaping care standards. The ability to deliver customized care while improving efficiency will drive wider acceptance and long-term market expansion.
Pressure Ulcers Treatment Market Competitive Landscape Analysis
Key players in Pressure Ulcers Treatment Market include;
- Smith & Nephew plc
- Integra LifeSciences Corporation
- Hill-Rom Holdings, Inc.
- Mölnlycke Health Care AB
- Essity Aktiebolag
- Cardinal Health
- 3M Healthcare
- B. Braun Melsungen AG
- Acelity L.P., Inc.
- Coloplast Group
- ConvaTec
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Type of Wound
- Market Snapshot, By End Users
- Market Snapshot, By Region
- Pressure Ulcers Treatment Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Rising Prevalence Of Chronic Bedridden Conditions
- Increasing Geriatric And Immobile Patient Population
- Advancements In Wound Healing Technologies
- Awareness Programs On Pressure Ulcer Prevention
- Restraints
- High Cost Of Advanced Treatment Products
- Limited Reimbursement In Certain Developing Regions
- Lack Of Trained Wound Care Specialists
- Product Access Gaps In Rural Settings
- Opportunities
- Technological Innovations In Dressing Materials
- Growing Demand For Home-Based Ulcer Care
- Public-Private Partnerships For Wound Management
- Integration Of AI In Ulcer Monitoring
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Pressure Ulcers Treatment Market, By Treatment Type, 2021 - 2031 (USD Million)
- Wound Care Dressings
- Antimicrobial Dressings
- Foam Dressings
- Hydrocolloid Dressings
- Film Dressings
- Alginate Dressings
- Hydrogel Dressings
- Other Dressings
- Wound Care Devices
- Negative Pressure Wound Therapy (NPWT)
- Ultrasound Therapy
- Others (HBOT and electromagnetic therapy)
- Active Therapies
- Skin Grafts & Substitutes
- Growth Factors
- Others (hemostatic agents, sealants (collagen and fibrin sealants))
- Others
- Traditional Wound Care Products
- Pressure Relief Devices
- Others
- Wound Care Dressings
- Pressure Ulcers Treatment Market, By Type of Wound, 2021 - 2031 (USD Million)
- Stage 1
- Stage 2
- Stage 3
- Stage 4
- Pressure Ulcers Treatment Market, By End Users, 2021 - 2031 (USD Million)
- Hospital Inpatient Settings
- Hospital Outpatient Settings
- Community Health Centers
- Home Health Care
- Pressure Ulcers Treatment Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Pressure Ulcers Treatment Market, By Treatment Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Smith & Nephew plc
- Integra LifeSciences Corporation
- Hill-Rom Holdings, Inc.
- Mölnlycke Health Care AB
- Essity Aktiebolag
- Cardinal Health
- 3M Healthcare
- B. Braun Melsungen AG
- Acelity L.P., Inc.
- Coloplast Group
- ConvaTec
- Company Profiles
- Analyst Views
- Future Outlook of the Market